HQL
Tekla Life Sciences Investors
1W: -6.8%
1M: -15.8%
3M: -12.3%
YTD: +8.9%
1Y: +15.6%
3Y: +88.6%
5Y: +31.6%
$17.68
-0.49 (-2.70%)
Weekly Expected Move ±3.3%
$17
$17
$18
$18
$19
Portfolio Health Summary
IS Overall Score
40.5
★★★★★
Altman Z-Score
18.99
Safe
Weight Coverage
84%
of portfolio analyzed
Holdings Matched
77
with fundamental data
InsiderStreet Scorecard
★★★★★
40.5
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
18.99
Safe Zone (>2.99)
Piotroski F-Score
3.4 / 9
Weak
Beneish M-Score
-1.00
Possible Manipulator
Credit Score
—
Earnings Quality
51.5 / 100
Portfolio Valuation
P/E
33.00x
P/B
4.84x
P/S
8.41x
EV/EBITDA
33.77x
EV/Revenue
9.15x
P/FCF
38.74x
P/OCF
34.55x
PEG
3.03x
Earnings Yield
3.03%
FCF Yield
2.58%
OCF Yield
2.89%
Median P/E
-7.37x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+42.4%
Net Income
-10.7%
EPS
+5.0%
FCF
-2.2%
EBITDA
-7.8%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+43.0%
Rev CAGR 5Y
+34.8%
EPS CAGR 3Y
+10.9%
EPS CAGR 5Y
+16.4%
FCF CAGR 3Y
+12.1%
FCF CAGR 5Y
+82.1%
EBITDA CAGR 3Y
+4.5%
EBITDA CAGR 5Y
+4.9%
Payout Ratio
4.27%
Buyback Yield
0.17%
Dividend Yield
0.04%
Total Shareholder Return
-10.03%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$17.67
Median 1Y
$19.12
5th Pctile
$13.01
95th Pctile
$28.14
Ann. Volatility
23.2%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 33.00 |
| Portfolio P/B | 4.84 |
| Portfolio P/S | 8.41 |
| EV/EBITDA | 33.77 |
| EV/Revenue | 9.15 |
| P/FCF | 38.74 |
| P/OCF | 34.55 |
| PEG | 3.03 |
| Earnings Yield | 3.03% |
| FCF Yield | 2.58% |
| OCF Yield | 2.89% |
| Median P/E | -7.37 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 86.14% |
| Operating Margin | -0.52% |
| Net Margin | -1.33% |
| FCF Margin | 0.06% |
| ROE | -0.83% |
| ROA | -0.51% |
| ROIC | 2.13% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.37 |
| Debt/Assets | 0.23 |
| Net Debt/EBITDA | -1.19 |
| Interest Coverage | -0.23 |
| Current Ratio | 3.19 |
| Quick Ratio | 2.94 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 42.35% |
| Net Income Growth | -10.70% |
| EPS Growth | 4.95% |
| FCF Growth | -2.22% |
| EBITDA Growth | -7.77% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 43.00% |
| Revenue CAGR 5Y | 34.78% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 10.89% |
| EPS CAGR 5Y | 16.40% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 12.10% |
| FCF CAGR 5Y | 82.08% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 4.52% |
| EBITDA CAGR 5Y | 4.93% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 9.76% |
| Net Income CAGR 5Y | 17.17% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 40.5 |
| IS Profitability | 33.0 |
| IS Balance Sheet | 55.4 |
| IS Earnings Quality | 51.5 |
| IS Growth | 53.4 |
| IS Value | 34.6 |
| IS Momentum | 55.4 |
| IS Safety | 75.3 |
| IS Quality | 45.7 |
| Altman Z-Score | 18.99 |
| Piotroski F-Score | 3.39 |
| Beneish M-Score | -1.00 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.04% |
| Payout Ratio | 4.27% |
| Buyback Yield | 0.17% |
| Total Shareholder Return | -10.03% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.673 |
| Earnings Stability | 0.557 |
| Earnings Persistence | 0.728 |
| Margin Stability | 0.530 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -7.37 |
| Median P/B | 4.08 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 83.55% |
| Holdings Matched | 77 |
| Total Holdings | 82 |